Kouros Owzar, PhD

Dr. Owzar is Professor of Biostatistics and Bioinformatics at Duke University School of Medicine, Director of Bioinformatics at the Duke Cancer Institute, and Director of Biostatistics for the Radiation Countermeasures Center of Research Excellence at Duke. His research is focused on the development of statistical methods and computational tools for investigating the role of heritability on cancer drug induced adverse events. Dr. Owzar is a member of the Duke Cancer Institute Executive Committee, lead statistician of the Alliance Pharmacogenomics and Population Pharmacology committee, and a co-investigator of the Global Alliance for Pharmacogenomics, a joint research program between the National Institutes of Health and the Center for Genomic Medicine in Japan at the RIKEN Institute.